XML 39 R28.htm IDEA: XBRL DOCUMENT

License Agreement (Details Narrative) - USD ($)		12 Months Ended
License Agreement (Details Narrative) - USD ($)	Dec. 25, 2015	Dec. 31, 2015	Dec. 31, 2014
Licensing fee revenue		$ 200,000
License Agreement [Member] \| Taipei Medical University [Member]
Non-refundable milestone payments	$ 200,000
License Agreement [Member] \| Taipei Medical University [Member] \| Cumulative Net Sales [Member]
Royalty percentage	10.00%
License Agreement [Member] \| Taipei Medical University [Member] \| Non-Sale Based Sub-License Income [Member] \| Minimum [Member]
Royalty percentage	10.00%
License Agreement [Member] \| Taipei Medical University [Member] \| Non-Sale Based Sub-License Income [Member] \| Maximum [Member]
Royalty percentage	15.00%
License Agreement [Member] \| Taipei Medical University [Member] \| First Phase 1b/2 Clinical Trial [Member]
Non-refundable milestone payments	$ 50,000
License Agreement [Member] \| Taipei Medical University [Member] \| First Phase 3 Clinical Trial [Member]
Non-refundable milestone payments	150,000
License Agreement [Member] \| Taipei Medical University [Member] \| First Filing of New Drug Application [Member]
Non-refundable milestone payments	200,000
License Agreement [Member] \| Taipei Medical University [Member] \| March 18, 2016 [Member]
Non-refundable milestone payments	$ 200,000